Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03531 | 33966916 | Arch Med Res | Hepatic Accumulation of Hypoxanthine: A Link Between Hyperuricemia and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03532 | 33966599 | Autophagy | Lipotoxicity reduces DDX58/Rig-1 expression and activity leading to impaired autophagy and cell death. | 2021 | Details |
| A03533 | 33965728 | Biomed Pharmacother | Açaí (Euterpe oleracea Martius) supplementation improves oxidative stress biomarkers in liver tissue of dams fed a high-fat diet and increases antioxidant enzymes' gene expression in offspring. | 2021 | Details |
| A03534 | 33965578 | Clin Gastroenterol Hepatol | Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. | 2021 | Details |
| A03535 | 33965533 | J Nutr Biochem | Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder. | 2021 | Details |
| A03536 | 33965477 | J Hepatol | Surveillance of patients with cirrhosis remains suboptimal in the United States. | 2021 | Details |
| A03537 | 33965368 | Arch Biochem Biophys | Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats. | 2021 | Details |
| A03538 | 33964370 | J Hepatol | Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. | 2021 | Details |
| A03539 | 33963602 | Clin Transplant | Magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF) is a viable alternative to liver biopsy for steatosis quantification in living liver donor transplantation. | 2021 | Details |
| A03540 | 33962692 | Microbiome | Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. | 2021 | Details |
| A03541 | 33962617 | Health Qual Life Outcomes | Health-related quality of life in Chinese population with non-alcoholic fatty liver disease: a national multicenter survey. | 2021 | Details |
| A03542 | 33962276 | Ecotoxicol Environ Saf | Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011-2014). | 2021 | Details |
| A03543 | 33962045 | Ann Hepatol | Assessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy. | 2021 | Details |
| A03544 | 33961941 | J Hepatol | Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression. | 2021 | Details |
| A03545 | 33961787 | Lancet Gastroenterol Hepatol | Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. | 2021 | Details |
| A03548 | 33961538 | Nanotoxicology | Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload. | 2021 | Details |
| A03549 | 33961302 | Hepatology | The Emerging Role of B Cells in the Pathogenesis of NAFLD. | 2021 | Details |
| A03550 | 33960934 | Turk J Gastroenterol | Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03551 | 33960342 | Food Funct | Functional milk fat enriched in conjugated linoleic acid prevented liver lipid accumulation induced by a high-fat diet in male rats. | 2021 | Details |
| A03552 | 33960110 | Obes Rev | Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat-A systematic review and meta-analysis. | 2021 | Details |
| A03554 | 33957975 | BMC Res Notes | Association of 45-bp ins/del polymorphism of uncoupling protein 2 (UCP2) and susceptibility to nonalcoholic fatty liver and type 2 diabetes mellitus in North-west of Iran. | 2021 | Details |
| A03555 | 33957803 | Exp Biol Med (Maywood) | Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. | 2021 | Details |
| A03556 | 33957682 | Semin Liver Dis | New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03557 | 33955511 | Mol Med Rep | Circulating microRNA‑135a‑3p in serum extracellular vesicles as a potential biological marker of non‑alcoholic fatty liver disease. | 2021 | Details |
| A03558 | 33955510 | Mol Med Rep | Parthenolide plays a protective role in the liver of mice with metabolic dysfunction‑associated fatty liver disease through the activation of the HIPPO pathway. | 2021 | Details |
| A03559 | 33953864 | Iran J Basic Med Sci | Gallic acid treats dust-induced NAFLD in rats by improving the liver's anti-oxidant capacity and inhibiting ROS/NFκβ/TNFα inflammatory pathway. | 2021 | Details |
| A03560 | 33953830 | Oxid Med Cell Longev | Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway. | 2021 | Details |
| A03561 | 33953700 | Front Endocrinol (Lausanne) | Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway. | 2021 | Details |
| A03562 | 33953586 | Diabetes Metab Syndr Obes | Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03563 | 33953582 | Diabetes Metab Syndr Obes | Correlation Between 25-Hydroxyvitamin D Level and Cardiac Diastolic Dysfunction in Chinese Adults with Early-Onset Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
| A03564 | 33952843 | Nihon Yakurigaku Zasshi | [The roles of gap junctional intercellular communication in non-alcoholic steatohepatitis (NASH) and liver fibrosis]. | 2021 | Details |
| A03565 | 33952449 | Anticancer Res | Obesity and Liver Cancer in Japan: A Comprehensive Review. | 2021 | Details |
| A03566 | 33952255 | Lipids Health Dis | Screening for the presence of scleroedema adultorum of Buschke in patients with diabetes mellitus: newly diagnosed patients had a high prevalence of dyslipidaemia. | 2021 | Details |
| A03567 | 33951744 | Andrologia | Predicting risk of erectile dysfunction in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03568 | 33951646 | Dig Dis | Abnormal Liver Blood Tests: Primary Care Approach. | 2021 | Details |
| A03569 | 33951121 | J Gastrointestin Liver Dis | Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan. | 2021 | Details |
| A03570 | 33951119 | J Gastrointestin Liver Dis | The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome. | 2021 | Details |
| A03571 | 33950921 | Medicine (Baltimore) | Serum markers for predicting advanced fibrosis in patients with chronic hepatitis B and nonalcoholic fatty liver disease. | 2021 | Details |
| A03572 | 33948987 | FASEB J | Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. | 2021 | Details |
| A03573 | 33948069 | Ann Gastroenterol | Evaluation of subclinical cardiac damage in biopsy-proven nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A03574 | 33948068 | Ann Gastroenterol | Effectiveness of dietary interventions on cardio-metabolic risk factors in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Details |
| A03575 | 33948067 | Ann Gastroenterol | Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis. | 2021 | Details |
| A03577 | 33947727 | BMJ Open | Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. | 2021 | Details |
| A03578 | 33947572 | Mater Sci Eng C Mater Biol Appl | Nano-encapsulation of hydroxytyrosol into formulated nanogels improves therapeutic effects against hepatic steatosis: An in vitro study. | 2021 | Details |
| A03579 | 33946843 | Microorganisms | Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. | 2021 | Details |
| A03580 | 33946377 | Medicina (Kaunas) | The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis. | 2021 | Details |
| A03581 | 33946154 | Microorganisms | High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. | 2021 | Details |
| A03582 | 33945507 | JCI Insight | Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis. | 2021 | Details |
| A03583 | 33943028 | J Diabetes Investig | Liver fibrosis is independently associated with diabetic peripheral neuropathy in type 2 diabetes mellitus. | 2021 | Details |
| A03584 | 33942524 | Pediatr Obes | Association between ectopic pancreatic and hepatic fat and metabolic risk factors in children with non-alcoholic fatty liver disease. | 2021 | Details |
| A03585 | 33941551 | BMJ Open Diabetes Res Care | Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels. | 2021 | Details |
| A03586 | 33941292 | J Health Popul Nutr | Study on the independent effect of thyroid hormone based on uric acid level on NAFLD. | 2021 | Details |
| A03587 | 33941179 | Biomed Eng Online | Viscoelasticity measured by shear wave elastography in a rat model of nonalcoholic fatty liver disease: comparison with dynamic mechanical analysis. | 2021 | Details |
| A03588 | 33940220 | Ann Hepatol | Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice. | 2021 | Details |
| A03589 | 33939897 | J Pediatr Endocrinol Metab | Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial. | 2021 | Details |
| A03590 | 33939383 | Clin Transl Gastroenterol | Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2021 | Details |
| A03592 | 33939147 | Dig Dis Sci | Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03593 | 33939118 | Drugs | Targeting AMPK by Statins: A Potential Therapeutic Approach. | 2021 | Details |
| A03594 | 33938630 | Liver Int | Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis. | 2021 | Details |
| A03595 | 33938212 | Environ Sci Technol | Nonalcoholic Fatty Liver Disease Development in Zebrafish upon Exposure to Bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate, a Novel Brominated Flame Retardant. | 2021 | Details |
| A03596 | 33938135 | Liver Int | Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial. | 2021 | Details |
| A03597 | 33937307 | Front Nutr | Variation in Lifestyle-Related Behavior Among Obese Indian Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03598 | 33937292 | Front Med (Lausanne) | Test-Retest Reliability of the Assessment of Fatty Liver Disease Using Low-Dose Computed Tomography in Cardiac Patients. | 2021 | Details |
| A03599 | 33937277 | Front Med (Lausanne) | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. | 2021 | Details |
| A03600 | 33937257 | Front Cell Dev Biol | Autophagy in Hepatic Steatosis: A Structured Review. | 2021 | Details |
| A03601 | 33936094 | Front Immunol | The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
| A03602 | 33935810 | Front Physiol | Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03603 | 33935770 | Front Pharmacol | Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03604 | 33935282 | Int J Obes (Lond) | The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. | 2021 | Details |
| A03605 | 33934381 | Hepatology | Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk. | 2021 | Details |
| A03606 | 33933462 | Exp Neurol | Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits. | 2021 | Details |
| A03607 | 33933056 | BMC Endocr Disord | Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis. | 2021 | Details |
| A03608 | 33933019 | BMC Gastroenterol | Spinach consumption and nonalcoholic fatty liver disease among adults: a case-control study. | 2021 | Details |
| A03609 | 33932956 | J Physiol | NAD+ and NAFLD - caution, causality and careful optimism. | 2021 | Details |
| A03610 | 33932796 | Clin Nutr | Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink. | 2021 | Details |
| A03612 | 33931568 | Sci Immunol | Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases. | 2021 | Details |
| A03613 | 33931283 | Ultrasound Med Biol | Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep Tissue. | 2021 | Details |
| A03614 | 33930596 | Mol Metab | Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A03615 | 33930586 | Clin Res Hepatol Gastroenterol | Pathogenetic mechanisms of nonalcoholic fatty liver disease and inhibition of the inflammasome as a new therapeutic target. | 2021 | Details |
| A03616 | 33930463 | J Biol Chem | NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet. | 2021 | Details |
| A03617 | 33929864 | J Proteome Res | A Panel of Glycopeptides as Candidate Biomarkers for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation. | 2021 | Details |
| A03618 | 33928675 | Hepatology | Inhibition of Secretin/Secretin Receptor Axis Ameliorates NAFLD Phenotypes. | 2021 | Details |
| A03619 | 33928671 | Hepatology | Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art. | 2021 | Details |
| A03620 | 33928009 | Clin Nephrol Case Stud | Severe type-B lactic acidosis in a patient with bilateral renal Burkitt's lymphoma. | 2021 | Details |
| A03621 | 33927697 | Front Endocrinol (Lausanne) | Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. | 2021 | Details |
| A03622 | 33926132 | Metabolites | Dietary Macronutrient Composition Differentially Modulates the Remodeling of Mitochondrial Oxidative Metabolism during NAFLD. | 2021 | Details |
| A03623 | 33926085 | Genes (Basel) | The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD. | 2021 | Details |
| A03624 | 33926073 | Diagnostics (Basel) | Quantification of Liver Fibrosis, Steatosis, and Viscosity Using Multiparametric Ultrasound in Patients with Non-Alcoholic Liver Disease: A "Real-Life" Cohort Study. | 2021 | Details |
| A03625 | 33925992 | J Clin Med | Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis. | 2021 | Details |
| A03626 | 33925827 | Int J Mol Sci | Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. | 2021 | Details |
| A03627 | 33925569 | Diagnostics (Basel) | Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03628 | 33925122 | Curr Issues Mol Biol | Effect of Bombyx mori on the Liver Protection of Non-Alcoholic Fatty Liver Disease Based on In Vitro and In Vivo Models. | 2021 | Details |
| A03629 | 33924909 | Diagnostics (Basel) | Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome. | 2021 | Details |
| A03630 | 33924725 | Nutrients | The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice. | 2021 | Details |
| A03631 | 33924165 | Int J Mol Sci | Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03632 | 33924115 | Int J Mol Sci | Chronic High Fat Diet Intake Impairs Hepatic Metabolic Parameters in Ovariectomized Sirt3 KO Mice. | 2021 | Details |
| A03633 | 33923817 | Int J Mol Sci | Role of Insulin Resistance in MAFLD. | 2021 | Details |
| A03634 | 33923656 | Molecules | Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. | 2021 | Details |
| A03635 | 33923525 | Nutrients | The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. | 2021 | Details |
| A03636 | 33923418 | J Clin Med | Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome. | 2021 | Details |